Literature DB >> 19889291

Chronic tension-type headache.

Jessica Ailani1.   

Abstract

Tension-type headache is the most common headache type worldwide. Chronic tension-type headache (CTTH) affects 2% to 3% of patients, yet it represents the least talked about subtype of chronic daily headache. There is much debate in the headache community on whether CTTH exists as its own entity or is a milder form of chronic migraine (CM), because there are similarities and differences between the two headache forms. This article reviews CTTH, as well as the current pathophysiology and treatment, and discusses controversial issues in the diagnosis of CTTH and CM.

Entities:  

Mesh：

Year:  2009        PMID： 19889291     DOI： 10.1007/s11916-009-0077-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  31 in total

1.  In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache.

Authors:  M Ashina; B Stallknecht; L Bendtsen; J F Pedersen; H Galbo; P Dalgaard; J Olesen
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

2.  Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators.

Authors:  Yvonne Nestoriuc; Winfried Rief; Alexandra Martin
Journal:  J Consult Clin Psychol       Date:  2008-06

3.  A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.

Authors:  C Lampl; S Marecek; A May; L Bendtsen
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

Review 4.  The global burden of headache: a documentation of headache prevalence and disability worldwide.

Authors:  Lj Stovner; K Hagen; R Jensen; Z Katsarava; Rb Lipton; Ai Scher; Tj Steiner; J-A Zwart
Journal:  Cephalalgia       Date:  2007-03       Impact factor: 6.292

Review 5.  Central sensitization in tension-type headache--possible pathophysiological mechanisms.

Authors:  L Bendtsen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

6.  Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Authors:  R Norman Harden; Jerod Cottrill; Christine M Gagnon; Todd A Smitherman; Stephan R Weinland; Beverley Tann; Petra Joseph; Thomas S Lee; Timothy T Houle
Journal:  Headache       Date:  2008-10-24       Impact factor: 5.887

Review 7.  Tension-type headache.

Authors:  Lars Bendtsen; Rigmor Jensen
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

Review 8.  Current and potential future drug therapies for tension-type headache.

Authors:  Sait Ashina; Messoud Ashina
Journal:  Curr Pain Headache Rep       Date:  2003-12

9.  Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial.

Authors:  M Ashina; L H Lassen; L Bendtsen; R Jensen; J Olesen
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

10.  An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache.

Authors:  Fernando M Volpe
Journal:  J Clin Psychiatry       Date:  2008-09       Impact factor: 4.384
View more
  1 in total

1.  Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients.

Authors:  Chris Della Vedova; Stuart Cathcart; Alan Dohnalek; Vanessa Lee; Mark R Hutchinson; Maarten A Immink; John Hayball
Journal:  Pain Res Manag       Date:  2013-08-16       Impact factor: 3.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.